It is important to note that medical cannabis treatment was generally well-tolerated by patients. Adverse effects were mild and included sleepiness, appetite changes, and irritability. However, no serious adverse events were reported.
The study also found that patients who were treated with cannabis products containing higher levels of cannabidiol (CBD) tended to have better clinical outcomes than those treated with products containing higher levels of tetrahydrocannabinol (THC). This is consistent with previous research suggesting that CBD may have neuroprotective and anti-inflammatory properties, while THC may have psychoactive effects.
Despite these promising results, it is important to note that medical cannabis treatment for ASD is not yet widely accepted by the medical community. The study’s authors emphasize the need for further research to better understand the potential benefits and risks of medical cannabis for individuals with ASD.
In conclusion, the recent study suggests that medical cannabis treatment may have potential therapeutic benefits for individuals with ASD. However, more research is needed to confirm these findings and to better understand the potential risks and benefits of medical cannabis for this population.
If you are considering medical cannabis treatment for yourself or a loved one with autism spectrum disorder, it is important to speak with a qualified healthcare provider who can provide guidance and support.
Post courtesy of @CryptoRick423 🎸 and Weed.Army.